AMENDED NOTE EXTENSION AGREEMENTAmended Note Extension Agreement • October 21st, 2019 • Accelerated Pharma, Inc. • Pharmaceutical preparations
Contract Type FiledOctober 21st, 2019 Company IndustryThis Amended Note Extension Agreement (“Amended Extension Agreement”), is made and entered into this 30th day of May 2019, effective as of January 30, 2019 (the “Effective Date”), by and among Accelerated Pharma, Inc., a Delaware corporation (the “Company”), and the parties (each a “Note Holder” and collectively, the “Note Holders”) identified on the Note Holder Conversion Schedule attached hereto. The Company and the Note Holders are sometimes referred to individually, as a “Party” and collectively, as the “Parties.”